PMV Pharmaceuticals, Inc.
PMVP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $41 | $38 | $108 | $172 |
| Short-Term Investments | $129 | $165 | $133 | $125 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $4 | $6 | $4 |
| Total Curr. Assets | $176 | $207 | $247 | $301 |
| Property Plant & Equip (Net) | $2 | $19 | $20 | $13 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $14 | $26 | $2 | $17 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $16 | $45 | $23 | $30 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $191 | $252 | $270 | $332 |
| Liabilities | – | – | – | – |
| Payables | $7 | $3 | $3 | $3 |
| Short-Term Debt | $0 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $10 | $7 | $9 |
| Total Curr. Liab. | $14 | $14 | $11 | $12 |
| LT Debt | $1 | $12 | $13 | $11 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $12 | $13 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $13 | $14 | $11 |
| Total Liabilities | $15 | $26 | $24 | $23 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$369 | -$310 | -$241 | -$168 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $545 | $535 | $488 | $476 |
| Total Equity | $176 | $226 | $246 | $309 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $191 | $252 | $270 | $332 |
| Net Debt | -$40 | -$24 | -$94 | -$161 |